1085458-80-5Relevant academic research and scientific papers
PYRAZOLOPYRIMIDINE INHIBITORS OF IRAK4 ACTIVITY
-
Page/Page column 80, (2016/09/26)
The present invention relates to pyrazolopyrimidine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
OXO BRIDGED DIAZEPAN OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 36, (2009/01/20)
The present invention is directed to oxo bridged diazepan compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
